Moreover, amongst CD8+ T cells, more Ki67+ GrzB+ effector T cells and a population of CD69+ CD103+ tissue-resident memory T cells (TRM) were induced (Figs. 6D and EV5B); TRM have been associated with improved clinical outcome in TNBC patients and CD103+ tumor-infiltrating lymphocytes are essential for eribulin-mediated anti-tumor effects in mice (Oya et al, 2023; Virassamy et al, 2023). Here, MKI67 is linked to neoplasm.